Inside Innovation

Seattle-based biotech company Kineta will receive $5 million from Merck after achieving a milestone in development efforts. Although Kineta is centered around oncology and cancer

A professor at the University of Washington School of Medicine teamed up with Seattle biotech company RareCyte, Inc. to create a blood test that measures

Seattle-based biotech company AltPep has raised $52.9 million in a Series B round. The funding follows previous investments of $44.4 million in 2022 and $23

Seattle-based Fred Hutchinson Cancer Center will extend its education offerings to eastern Washington this summer during a three-week STEM program for teachers. The announcement follows

Vulcan Inc., a Seattle-based development and real estate company, will move forward with the construction of a lab research facility after receiving approval from a

Seattle-based biotech company Seagen appears to have found success with a drug in its phase II trials of early-stage classical Hodgkin lymphoma, with 93% of

Life Science Washington Institute announced two new grant programs at its annual East West Summit. The grants will be used to fund life sciences startups

OtoNexus Medical Technologies, a Bellevue-based company, is among Puget Sound Business Journal’s “Washington’s 100 best workplaces.” OtoNexus is one of only 25 small companies –

Novartis announced that it will be purchasing Chinook Therapeutics, a Seattle-based biotech company, for $3.2 billion. Founded in 2019, Chinook Therapeutics focuses on developing treatments

Seattle-based biotech company Variant Bio will be creating new therapeutic programs to enhance its current research on genomic variants. The addition of Dr. David Moller

Seagen, a Bothell biotech company, is set to be acquired by Pfizer Pharmaceuticals following a shareholder vote on May 30. The $43 billion purchase is